Caplin Point Laboratories Ltd. logo

Caplin Point Laboratories Ltd. (CAPLIPOINT)

Market Closed
15 Dec, 10:00
XNSE XNSE
1,955. 60
-8.3
-0.42%
- Market Cap
- P/E Ratio
10% Div Yield
20,126 Volume
- Eps
1,963.9
Previous Close
Day Range
1,944 1,969.5
Year Range
1,599 2,641
Want to track CAPLIPOINT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days

Summary

CAPLIPOINT closed today lower at ₹1,955.6, a decrease of 0.42% from yesterday's close, completing a monthly increase of 1.06% or ₹20.6. Over the past 12 months, CAPLIPOINT stock lost -22.24%.
CAPLIPOINT pays dividends to its shareholders, with the most recent payment made on Oct 21, 2025. The next estimated payment will be in In 1 month on Jan 21, 2026 for a total of ₹3.
The last earnings report, released on Nov 05, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
Caplin Point Laboratories Ltd. has completed 1 stock splits, with the recent split occurring on Oct 19, 2016.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on MSE (INR).

CAPLIPOINT Chart

Caplin Point Laboratories Ltd. (CAPLIPOINT) FAQ

What is the stock price today?

The current price is ₹1,955.60.

On which exchange is it traded?

Caplin Point Laboratories Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is CAPLIPOINT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 05, 2026.

Has Caplin Point Laboratories Ltd. ever had a stock split?

Caplin Point Laboratories Ltd. had 1 splits and the recent split was on Oct 19, 2016.

Caplin Point Laboratories Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
XNSE Exchange
INE475E01026 ISIN
India Country
1,642 Employees
- Last Dividend
19 Oct 2016 Last Split
- IPO Date

Overview

Caplin Point Laboratories Limited is a distinguished entity in the pharmaceutical domain, actively involved in the development, production, marketing, and export of generic pharmaceutical formulations along with branded products primarily within India. Since its inception in 1990, Caplin Point has consistently expanded its footprint, excelling in the pharmaceutical sector by leveraging its comprehensive suite of products and state-of-the-art manufacturing capabilities. With its headquarters located in Chennai, India, the company has built a reputation for its commitment to quality, innovation, and accessibility in healthcare solutions, reaching out to a broad spectrum of patients and healthcare providers not only domestically but across the globe.

Products and Services

Caplin Point Laboratories Limited offers a diverse range of pharmaceutical products and services, designed to cater to various healthcare needs. Below is an overview of their key offerings:

  • Liquid and Lyophilized Vials: These products include both liquid and freeze-dried formulations that are used for injectable medications. Lyophilized vials are notable for their long shelf-life and ease of transport, requiring reconstitution before administration to patients.
  • Pre-filled Syringes: Offering convenience and efficiency, pre-filled syringes are ready-to-administer doses of injectable medications. They enhance safety by minimizing the risk of dosing errors and contamination.
  • 3-pc Ophthalmic Droppers: These are specialized dropper systems designed for the precise delivery of medication to the eyes. They are typically used for treatments related to eye diseases and conditions.
  • Pre-mix Bags: Used mainly in hospital settings, pre-mix bags contain medications that are pre-mixed and ready for infusion. These products ensure accuracy and save preparation time in critical care scenarios.
  • Dry and Liquid Syrups-Bottles: This range includes both dry syrups that require reconstitution before use and liquid syrups, provided in bottles for oral administration to treat various conditions.
  • Tablets, Soft Gels, Capsules: These solid dosage forms are the backbone of oral pharmaceuticals, designed to deliver medication in precise doses. The variety includes conventional tablets, soft gel capsules for easier swallowing, and hard-shell capsules.
  • Suppositories: Formulated for insertion into rectal or vaginal cavities, suppositories are used for medications that are better absorbed or less irritant in these areas compared to oral administration.
  • Liquid and Emulsion Injectables in Ampoules and Vials: These injectable formulations, supplied in ampoules and vials, are used for intravenous, intramuscular, or subcutaneous injections, depending on the medication and condition being treated.
  • Topicals: Including creams, ointments, gels, and lotions, topicals are applied to the skin surface to treat various dermatological conditions or deliver active ingredients directly through the skin.
  • Sachets: Sachet-packed powders or granules are designed for dissolution in water or another liquid before intake. They offer convenience and dosing precision for oral medications.

Contact Information

Address: Ashvich Tower
Phone: 91 44 2496 8000